Volume 42, Issue 5, Pages (May 2005)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Volume 53, Issue 1, Pages (July 2010)
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 61, Issue 4, Pages (October 2014)
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Volume 65, Issue 5, Pages (November 2016)
Volume 68, Issue 5, Pages (May 2018)
Volume 42, Issue 6, Pages (June 2005)
Volume 61, Issue 6, Pages (December 2014)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Volume 51, Issue 6, Pages (December 2009)
The impact of hepatitis E in the liver transplant setting
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 42, Issue 1, Pages (January 2005)
NS5A inhibitors in the treatment of hepatitis C
Immigration and viral hepatitis
Volume 66, Issue 1, Pages 1-4 (January 2017)
Ype P. de Jong, Charles M. Rice, Alexander Ploss  Journal of Hepatology 
Living donor liver transplantation: is the hype over?
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
The place of downstaging for hepatocellular carcinoma
Autoimmune hepatitis: A life-long disease
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
European Association for the Study of the Liver  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Volume 70, Issue 1, Pages (January 2019)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Volume 55, Issue 1, Pages (July 2011)
Severe Constipation Clinical Gastroenterology and Hepatology
EASL Clinical Practice Guidelines: Wilson’s disease
Volume 61, Issue 1, Pages S45-S57 (November 2014)
Economics of chronic hepatitis B and hepatitis C
Volume 65, Issue 2, Pages (August 2016)
EASL Clinical Practice Guidelines on hepatitis E virus infection
Volume 50, Issue 4, Pages (April 2009)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Volume 56, Issue 6, Pages (June 2012)
Immigration and viral hepatitis
HCV targeting of patients with cirrhosis
Immunological techniques in viral hepatitis
Volume 57, Issue 6, Pages (December 2012)
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
Volume 51, Issue 2, Pages (August 2009)
Chronic hepatitis B in children and adolescents
New trials and results in systemic treatment of HCC
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Volume 54, Issue 6, Pages (June 2011)
Volume 62, Issue 5, Pages (May 2015)
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Reversion of disease manifestations after HCV eradication
Presentation transcript:

Volume 42, Issue 5, Pages 615-624 (May 2005) SHORT STATEMENT OF THE FIRST EUROPEAN CONSENSUS CONFERENCE ON THE TREATMENT OF CHRONIC HEPATITIS B AND C IN HIV CO-INFECTED PATIENTS  Alfredo Alberti, Nathan Clumeck, Simon Collins, Wolfram Gerlich, Jens Lundgren, Giorgio Palù, Peter Reiss, Rodolphe Thiebaut, Ola Weiland, Yazdan Yazdanpanah, Stefan Zeuzem, (The ECC Jury)  Journal of Hepatology  Volume 42, Issue 5, Pages 615-624 (May 2005) DOI: 10.1016/j.jhep.2005.03.003 Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Management and therapeutic options in HBV/HIV co-infected patients with no immediate indication for HIV treatment. Journal of Hepatology 2005 42, 615-624DOI: (10.1016/j.jhep.2005.03.003) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Management and therapeutic options in HBV/HIV co-infected patients with an indication for anti-HIV therapy. Journal of Hepatology 2005 42, 615-624DOI: (10.1016/j.jhep.2005.03.003) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions